All open calls
    HORIZON-JU-IHI-2026-13-two-stage-02

    An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies

    OpenLive official EU data

    Innovative Health Initiative JU Call 13 · HORIZON-JU-RIA · Needs partners

    8 Oct 2026
    Deadline
    €9M
    Indicative, per project
    ~1
    Grants expected
    15
    Past winners in this family

    What this call funds

    This call funds a large collaborative project to build an AI model that predicts whether testing a new drug in a second animal species would actually reveal useful safety information. The goal is to let drug developers skip unnecessary second-species toxicity testing when the AI shows it wouldn't add value, cutting animal use, cost, and development time while keeping patients safe. Winners will build the AI model, a supporting decision framework, and work with regulators to get this approach officially accepted.

    artificial intelligence · machine learning · pharmaceuticals · digital health · research excellence

    Who wins this

    A large multi-stakeholder consortium including pharmaceutical companies, regulators, academic institutions and SMEs with access to toxicology data and AI modelling expertise, aiming to jointly develop and validate a regulator-endorsed AI toxicology model.

    Could you win this call?

    We read your site to see what you build.

    The call in detail

    Indicative grant size
    €9M
    Funding model
    Budget-based — reimbursement of actual eligible costs
    Submission
    Two-stage submission (short outline first, full proposal if invited)
    Cut-off dates (2)
    8 Oct 2026 · 21 Apr 2027
    Type of action
    HORIZON JU Research and Innovation Actions
    Partners
    Required. The call asks for a consortium — a group applying together, typically 3+ organisations from 3+ countries.
    Also required
    Legal entities based in countries associated to Horizon Europe, including Canada, Switzerland, the UK, and South Korea, are eligible; single applicant only expected to be one grant funded with a budget of 53.2M EUR.
    Eligible countries (45)
    Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Norway, Iceland, Switzerland, United Kingdom, IL, TR, UA, RS, MK, ME, AL, BA, XK, GE, AM, MD, TN, NZ
    Read the full conditions from the official call ›

    General conditions 1. Admissibility conditions: Proposal page limit and layout described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. Proposal page limits and layout: described in Part B of the Application Form available in the Submission System: at the first stage of a two-stage call, the limit for RIA short proposals is 20 pages; at the second stage of a two-stage call, the limit for RIA full proposals is 50 pages. 2. Eligible countries described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide. 3. Other Eligibility Conditions described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP) 4. Financial and operational capacity and exclusion described in Annex C of the Work Programme General Annexes. 5a. Evaluation and award: Award criteria, scoring and thresholds described in Annex D of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP) 5b. Evaluation and award: Submission and evaluation processes described in Annex F of the Work Programme General Annexes and the Online Manual. 5c. Evaluation and award: Indicative timeline for evaluation and grant agreement described in Annex F of the Work Programme General Annexes. 6. Legal and financial set-up of the grants described in Annex G of the Work Programme General Annexes. Specific conditions described in the ''Conditions of the Calls for proposals and Calls management rules'' section of the the IHI JU Work Programme (WP) specific conditions on Availability, Accessibility and Affordability (3A) do not apply to this topic JU's right to object to transfer/exclusive licensing Information on eligibility for funding: Legal entities based in all countries associated to Horizon Europe, including Canada, Switzerland, the UK, and South Korea, will be eligible to receive funding under this call, in line with the normal rules. Where relevant, templates of the reference documents and associated guidance can be found on the IHI JU website. Regarding the application forms for submitting proposals, the relevant templates and annexes are available to download in the submission system of the Funding and Tender Opportunities portal. The IHI JU 13 th Call for proposals full topics text is available here.

    Who has won calls like this

    Organisations that most often win this call family · 15 past winners

    NOVO NORDISK A/S · DK
    13 wins
    PFIZER INC · US
    10 wins
    Pfizer R&D UK Limited · UK
    10 wins
    NOVARTIS PHARMA AG · CH
    10 wins
    Sanofi US Services Inc. · US
    8 wins
    SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT · FR
    8 wins

    Similar open calls